三级片无码高清免费国产,中文字幕一区二区三区乱,国内精品久久久久久99蜜桃,亚洲一区电影网站在线观看

Stock(600222)Hot line:010-61006450

MAH

Leader of "0" Cost MAH 3.0 Era

Platform Overview

Platform Overview
————???????—???????—???????—???????—???????—???????—

 
The project Initiation service platform has more than 20 professional knowledge personnel, all from Shenyang Pharmaceutical University, Chinese Academy of Medical Sciences, Peking Union Medical College and other well-known universities at home and abroad, and has set up generic drug project strategy center, clinical & pharmacology center, intellectual property center, big data analysis center, international new product strategy center, based on the all-round analysis of the pharmaceutical industry and combined with the company's own differentiated positioning, can provide customers with personalized information technology services and comprehensive information assurance.

 Service Content

—???????—???????—???????—???????—???????—???????—???????—???????—???????—

1) Generic Drug Project Initiation: Project development risk assessment is carried out through comprehensive analysis of listed product information, including review overview, patents, market prospects, competition pattern, technical barriers, policy dynamics and other mainstream regulatory countries in Europe, the United States, Japan, China, Canada, Australia and other mainstream regulatory countries.
???????

2)Improvement and Innovation Projects: According to the domestic clinical needs and the guidance of policies and regulations, look for potential improvement and innovation projects, conduct comprehensive research from the aspects of product clinical positioning, market value, competition dynamics, patent layout, and development and listing paths of such projects at home and abroad, determine the adequacy and feasibility of the basis for the topic, and conduct in-depth pharmaceutical technology evaluation, clinical evaluation, development cycle and cost evaluation of the proposed development project.
 

3) Strategy Consulting Service: According to the needs of enterprises, provide partners with product pipeline sustainable development planning, feasibility analysis of new entry fields, and R&D strategy formulation after policy changes, such as the development opportunities and challenges in the cardiovascular field, the key points of improved new drug technology research and development, the analysis of the clinical drug competition pattern of platforms (ophthalmic preparations, enteric-coatedpreparations, sustained-release preparations), and the monthly analysis report of CDE application acceptance products.
 

4)Patent Service: Patent layout of cooperation projects, patent risk assessment of new products, infringement analysis and circumvention strategies, patent search and analysis service, patent tracking and early warning analysis.

5)Resource sharing: The leadingpharm information department cooperates with many well-known pharmaceutical databases at home and abroad (cortellis, intranet, insight, wisdombud), which can provide domestic and foreign listing information, the latest information on industry policies, new products/targets at home and abroad, domestic and foreign product sales and forecast data, market access, clinical guidelines and clinical front-line drug consultation, etc.


 

 

 

 

 

 

 

亚洲日韩国产精品乱-久| 她也色在线视频色999| 国产精品久久久久久av福利| 亚洲欧美v国产蜜芽tv| 亚洲 色图 欧美 自拍| 亚洲欧美韩国综合色蜜芽| 亚洲a级亚洲男天堂无码| 九九视频免费在线观看精品| 午夜丰满性感少妇打炮视频| 国产99视频精品免视看9| 狼色精品人妻在线视频网站| 久久人人妻人人爱人人爽| 久久人午夜亚洲精品无码区| 丰满少妇大力进入av亚洲| 中文字幕中日韩欧美一区| 中文无码亚洲色偷偷a片| 日本av在线中文一区二区| 国产亚洲一区二区三不卡| 日本一区二区三区电影播放| 水蜜桃久久夜色精品国产| 日本在线免费观看午夜视频| 国内精品无码区二区三区| 在线91华人精品国产片| 国产综合av性色在线影院| 久久久久久午夜精品网站| 欧美视频日韩视频亚洲视频| 亚洲一区二区无码中字幕| 久久久久久久久人妻精品| 亚洲人成日韩中文字幕不| 国产av无码亚洲avh| 日韩毛片在线一区二区毛片| 美日韩精品视频在线观看| 亚洲精品高清无码视频| 激情综合一区二区三区| 亚洲成av人片乱码在线| 国产三级在线播放视频不卡| 成人三级A视频在线观看| 爱无码在线视频| 国产精品大秀视频日韩精品| 欧美多人玩3p视频一区| 欧美性生交18xxxxx无码|